Skip to main content

Leonard Kruimer, Peter Schineller

Skyline has appointed Leonard Kruimer as CFO, effective Aug. 15, and Peter Schineller as chief commercial officer, effective Aug. 1. Kruimer has more than 30 years of experience in corporate finance, planning, and strategy. He was CFO of Crucell from 1998 to 2011 when Johnson & Johnson acquired the firm. 

Schineller has 25 years of experience in the diagnostic and pharmaceutical spaces and most recently was CCO at Agendia. Prior to that, he was SVP and CCO at Alexza Pharmaceuticals. He previously held executive positions at Ventana Medical Systems and at Genoptix Medical Laboratories. He also was a co-founder of Verus Pharmaceuticals. 

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.